Mechanisms for Cisplatin-FUra Synergism and Cisplatin Resistance in Human Ovarian Carcinoma Cells both in vitro and in vivo
- 1 January 1988
- book chapter
- Published by Springer Nature
- Vol. 244, 127-135
- https://doi.org/10.1007/978-1-4684-5607-3_12
Abstract
Cisplatin and FUra act synergisticly in human carcinomas. An increase in the availability of reduced folates necessary for tight binding of FdUMP to thymidylate synthase (TS) contributes to the enhanced cytotoxicity of this drug combination. The human ovarian A2780 cell line made three-fold resistant to cisplatin has been shown to have a three-fold elevation of m-RNA for dihydrofolate reductase (DHFR) and TS. However, this increase did not result from an amplification of the genes for these two enzymes. In contrast, ovarian carcinoma cells from patients who failed treatment with cisplatin and FUra have been shown to have both enhanced gene expression and increased gene copy number for DHFR and TS.Keywords
This publication has 9 references indexed in Scilit:
- Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.Proceedings of the National Academy of Sciences, 1988
- Regulation of c-myc and c-fos proto-oncogene expression by animal cell growth factorsIn Vitro Cellular & Developmental Biology, 1988
- Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatinBiochemical Pharmacology, 1988
- Methionine metabolism defect in cells transfected with an activated HRAS1 oncogene*1Experimental Cell Research, 1987
- The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cellsCancer Chemotherapy and Pharmacology, 1987
- Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.Proceedings of the National Academy of Sciences, 1986
- Charles F. Kettring prize. Fundamental studies with cisplatinCancer, 1985
- Cellular genes analogous to retroviral onc genes are transcribed in human tumour cellsNature, 1982